Efficacy of epidermal growth factor receptor inhibitors in combination with chemotherapy in advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy of epidermal growth factor receptor inhibitors in combination with chemotherapy in advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

Published:2016-05-20 Issue:26 Volume:7 Page:39823-39833
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Minghui¹,Guo Hongsheng²,Zhao Shu¹,Wang Yan³,Yang Maopeng¹,Yu Jiawei¹,Yan Yubo¹,Wang Yan¹

Affiliation:

1. Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, China

2. Department of Medical Oncology, Tianjin Third Central Hospital, Tianjin, 300170, China

3. Department of Medical Oncology, Heilongjiang Provincial Hospital, Harbin, 150000, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?;Critical Reviews in Oncology/Hematology;2021-10

2. First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Frontiers in Oncology;2021-04-13

3. First-generation EGFR-TKI plus chemotherapy versus EGFR-TKI alone as first-line treatment in advanced NSCLC with EGFR activating mutation: a systematic review and meta-analysis of randomized controlled trials;2020-04-17

4. Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives;Critical Reviews in Oncology/Hematology;2020-02

5. The continued EGFR-TKI with cytotoxic chemotherapy at progression—poison or medicine?;Translational Lung Cancer Research;2018-04